Brief: Incyte - FDA Issues Complete Response Letter For Zynyz Sbla In Nsclc - SEC Filing
06/03/2026 22:07
March 6 (Reuters) - Incyte Corp INCY.O: INCYTE - FDA ISSUES COMPLETE RESPONSE LETTER FOR ZYNYZ SBLA IN NSCLC - SEC FILING INCYTE - CRL CITES CATALENT INDIANA REGULATORY COMPLIANCE AS SOLE APPROVABILITY ISSUE - SEC FILING Further company coverage: INCY.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Incyte
See all newsIncyte Corp reports results for the quarter ended September 30 - Earnings Summary
Incyte Q3 adjusted loss per share beats estimates
Revolution Medicines falls after Incyte posts competitive pancreatic cancer data
Factbox: Pharma sector doubles down on AI to slash costs, timelines
US RESEARCH ROUNDUP-Eli Lilly, Netflix, Zscaler